Revenue and Profitability - Revenue for Q3 2022 reached ¥241,396,484.57, an increase of 71.83% year-over-year, and a total of ¥506,007,421.43 for the year-to-date, up 55.26% compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2022 was ¥10,424,640.96, a decrease of 9.76% year-over-year, with a year-to-date net profit of ¥18,911,363.12, down 7.56%[3] - Basic earnings per share for Q3 2022 were ¥0.0851, down 19.94% year-over-year, and year-to-date earnings per share were ¥0.1546, down 17.55%[4] - The company reported a net profit margin improvement, with net profit figures to be detailed in the full report, indicating positive financial health moving forward[32] - The net profit for Q3 2022 was CNY 18,871,317.69, a decrease of 29.8% compared to CNY 26,872,481.47 in Q3 2021[34] - Operating profit for the quarter was CNY 18,260,817.15, down 33.4% from CNY 27,386,003.10 in the same period last year[34] - The company reported a total profit of CNY 20,542,936.47 for the quarter, a decrease of 28.2% from CNY 28,576,999.81 in Q3 2021[34] Assets and Liabilities - Total assets at the end of Q3 2022 amounted to ¥1,757,224,038.80, reflecting a 15.39% increase from the end of the previous year[4] - Total assets reached ¥1,757,224,038.80, an increase of 15.4% from ¥1,522,824,726.68 at the beginning of the year[31] - Total liabilities increased to ¥576,812,508.72, up from ¥442,680,141.41, marking a rise of 30.3%[31] - The company's equity attributable to shareholders rose to ¥1,180,114,403.70, compared to ¥1,079,897,413.46, reflecting a growth of 9.3%[31] Cash Flow and Investments - Cash flow from operating activities showed a net outflow of ¥16,408,311.38, a significant decline of 351.95% year-over-year[19] - The net cash flow from operating activities was negative CNY 16,408,311.38, compared to a positive CNY 6,512,605.81 in the previous year[37] - Investment activities generated a net cash inflow that increased by 37.85% year-over-year, driven by increased fixed asset investments[20] - Investment activities generated a net cash flow of CNY 34,883,863.15, compared to CNY 25,305,236.93 in the same quarter last year[37] - Financing activities resulted in a net cash flow of CNY 78,734,021.20, a significant improvement from a negative CNY 29,397,955.87 in Q3 2021[37] Operating Costs and Expenses - The company experienced a 95.23% increase in operating costs year-over-year, attributed to expanded revenue scale and increased costs from intensified competition and project delays[18] - Total operating costs amounted to ¥490,476,081.95, up 62.2% from ¥302,526,636.35 year-over-year, with operating costs specifically rising from ¥205,328,688.67 to ¥400,855,176.86[33] - Research and development expenses for the quarter were ¥26,384,599.10, an increase from ¥22,883,023.78 in the previous year, indicating a growth of 15.0%[33] - Financial expenses decreased by 138.21% year-over-year, mainly due to the redemption of convertible bonds issued in 2020[18] Shareholder Information - The top 10 unrestricted shareholders hold a total of 42,000,000 shares, with Shanghai Dehui Group Co., Ltd. being the largest shareholder at 32,000,000 shares[24] - The company has a total of 375,000 restricted shares held by executives, which are subject to a 25% annual release during their tenure[26] - The total number of restricted shares at the end of the period is 1,098,648, primarily due to executive lock-up agreements[27] - The company has implemented a strategy to manage executive share restrictions, ensuring that no more than 25% of their total shares can be transferred during their tenure[26] - As of July 20, 2022, 834,924 shares held by JPMorgan Chase Bank and 663,258 shares held by Chen Peng were released from restrictions[27] - The company has not disclosed any known relationships or concerted actions among the top shareholders[24] Market and Product Development - The report indicates that there are no new products or technologies mentioned in the current quarter[27] - There is no mention of market expansion or acquisitions in the current financial report[27] - The company has not provided specific future guidance or performance outlook in the current report[27] - The report does not include any significant changes in user data or customer metrics[27]

Capital Structure and Financial Position - The registered capital of the company increased from RMB 108,624,902 to RMB 122,642,024 during the reporting period[26]. - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves[5]. - The company’s total assets increased by 18.50% to ¥1,804,490,031.88 from ¥1,522,824,726.68 at the end of the previous year[27]. - The company’s equity attributable to shareholders increased to RMB 1,169,689,762.74 from RMB 1,079,897,413.46, reflecting a growth of about 8.3%[162]. - The total liabilities of the company were RMB 634,581,724.58 as of June 30, 2022, up from RMB 442,680,141.41, which is an increase of approximately 43.3%[162]. - The company reported a total of RMB 5,830,231.46 in other payables, which increased from RMB 3,968,461.88, showing a growth of about 46.8%[162]. - The company’s cash and cash equivalents increased significantly to RMB 208,027,371.63 from RMB 86,120,642.42, representing a growth of approximately 142.5%[160]. - The company reported a total of RMB 34,528.36 million in raised funds, with CNY 10,452.68 million invested during the reporting period[74]. - The company has CNY 172,253,586.79 in restricted assets, primarily due to guarantees for bank loans and bills[69]. Revenue and Profitability - The company's operating revenue for the current period is ¥264,610,936.86, representing a 42.71% increase compared to ¥185,422,934.59 in the same period last year[27]. - The net profit attributable to shareholders decreased by 4.71% to ¥8,486,722.16 from ¥8,906,046.49 year-on-year[27]. - The net profit for the first half of 2022 reached ¥9.74 million, up 15.1% from ¥8.47 million in the first half of 2021[172]. - The total profit for the first half of 2022 was approximately ¥9.25 million, compared to ¥8.45 million in the same period of 2021, marking a 9.5% increase[172]. - The gross profit margin for the membrane integration technology solutions was 18.55%, with a year-on-year decrease of 14.08%[62]. Research and Development - R&D expenses accounted for 5.89% of the revenue, with direct R&D investment amounting to 15.59 million yuan[50][54]. - The company has accumulated 69 invention patents, 119 utility model patents, and 5 design patents, with 106 patent applications under review[54]. - The company has developed lithium adsorption materials and is in the industrialization phase for these products, enhancing its separation material product range[50][53]. - Research and development expenses for the first half of 2022 were CNY 15,590,238.29, slightly up from CNY 15,232,980.20 in the same period last year, indicating a focus on innovation[168]. Market and Industry Position - The company operates in the high-tech sector, focusing on membrane technology and separation processes[15]. - The company is recognized as a leading enterprise in the ceramic membrane field by the China Membrane Industry Association[44]. - The rapid development of the lithium battery industry is driven by the growth of new energy vehicles, creating significant investment opportunities in lithium extraction technologies[46]. - The company has established a strategic cooperation agreement with Zijin Mining for lithium extraction process research, indicating strong industry partnerships[51]. - The company provides integrated membrane technology solutions for industries such as biomedicine, chemicals, and environmental water treatment[90]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report[4]. - The company’s financial report includes a detailed analysis of potential risks and countermeasures[4]. - The company is facing risks related to accounts receivable collection due to macroeconomic slowdown and increased financing costs, which may extend the payment cycle[91]. - The company has established a dedicated team to manage the collection of large or aged accounts receivable to mitigate financial pressure[91]. Environmental and Social Responsibility - The company is committed to environmental management and adheres to standards to reduce negative impacts on the environment[102]. - The company has not reported any significant environmental penalties during the reporting period[102]. - The company actively engages in social responsibility initiatives, including the establishment of the "Jiu Wu Scholarship" to support underprivileged students[105]. Governance and Compliance - The company has maintained a strict governance structure to protect the rights of shareholders and creditors since its listing[103]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties during the reporting period[110]. - The company has not engaged in any illegal external guarantees during the reporting period[111]. - The company has a clear profit distribution policy that aligns with regulatory requirements and investor feedback[103]. Shareholder and Equity Information - The total number of restricted shares increased from 2,116,875 to 5,010,555, representing 4.09% of total shares[136]. - The company issued 3,121,212 new shares in 2021, which were listed on the Shenzhen Stock Exchange on January 20, 2022[131]. - The total amount of funds raised by Jiangsu Jiuwu High-Tech Co., Ltd. was approximately ¥102.99 million, with a net amount of ¥99.70 million after deducting issuance costs[145]. - As of the end of the reporting period, the total number of ordinary shareholders was 25,471[146].

Revenue and Profitability - Revenue for Q1 2022 was CNY 104,790,149.72, an increase of 38.71% compared to CNY 75,546,621.76 in the same period last year[4] - Net profit attributable to shareholders decreased by 31.82% to CNY 4,525,876.10 from CNY 6,638,128.99 year-on-year[4] - Basic earnings per share fell by 38.47% to CNY 0.0379 from CNY 0.0616 in the previous year[5] - The company reported a net profit margin improvement, with retained earnings increasing to CNY 487,215,865.26 from CNY 482,689,989.15, a slight increase of about 0.11%[32] - Net profit for the current period was ¥4,505,549.48, down from ¥5,697,004.90 in the previous period, indicating a decrease of approximately 20.9%[35] Assets and Liabilities - Total assets increased by 10.32% to CNY 1,680,056,137.69 compared to CNY 1,522,824,726.68 at the end of the previous year[5] - The company's total liabilities increased to CNY 495,553,128.82 from CNY 442,680,141.41, indicating a rise in financial obligations[31] - Current assets totaled CNY 1,238,297,579.17, up from CNY 1,079,226,690.62 at the start of the year, reflecting a growth of approximately 14.77%[30] - The total current liabilities rose to CNY 418,516,005.75 from CNY 363,298,981.24, indicating an increase of approximately 15.19%[31] Cash Flow - Cash flow from operating activities decreased by 114.76% to CNY -3,904,397.30, primarily due to increased procurement and inventory[19] - The net cash flow from operating activities was negative at -¥3,904,397.30, a decline from a positive cash flow of ¥26,458,611.96 in the previous period[39] - Cash inflow from investment activities was ¥101,082,748.33, down from ¥161,603,390.41 in the previous period, showing a decrease of about 37.5%[39] - The net cash inflow from financing activities was ¥98,881,722.01, compared to a net outflow of ¥21,405,120.37 in the previous period[40] Operating Costs and Expenses - The company reported a 71.27% increase in operating costs, attributed to both expanded revenue scale and rising raw material prices[15] - Total operating costs amounted to ¥103,433,650.54, compared to ¥75,339,636.29 in the previous period, reflecting an increase of about 37.4%[33] - The company experienced a decrease in sales expenses to ¥8,908,588.84 from ¥9,846,032.33, a reduction of about 9.5%[33] - Research and development expenses were ¥6,083,127.26, slightly down from ¥6,425,786.76 in the previous period, reflecting a decrease of about 5.3%[33] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 28,319[22] - The company reported a total of 32,000,000 shares held by Shanghai Dehui Group, representing a significant portion of the unrestricted shares[24] - The total number of shares held by the top 10 unrestricted shareholders amounts to 42,000,000 shares, indicating concentrated ownership[24] - The total number of shares held by the top 10 shareholders participating in margin trading is 1,085,900 shares, indicating active trading strategies[24] Future Outlook and Strategic Plans - The company plans to expand its market presence through strategic partnerships and potential acquisitions in the upcoming quarters[26] - The company is focusing on R&D for new technologies to enhance product offerings and drive future growth[26] - The company anticipates a positive outlook for the next quarter, with expectations of increased revenue driven by new product launches[26] Investment Income - Investment income surged by 2148.76%, reflecting increased returns from investments in joint ventures and associates[18] - The company reported an investment income of ¥972,725.82, a significant increase from ¥43,256.13 in the previous period[35] Share Lock-up and Issuance - The company has 375,000 shares locked for executives, with 25% eligible for release annually, reflecting a structured share release plan[25] - The company issued 663,258 new shares to Chen Peng, which will not be transferred for 6 months from the listing date[26] - The company has a total of 834,924 shares locked for JPMorgan Chase, which will also not be transferred for 6 months from the listing date[26] - The company has a total of 643,750 shares locked for Shanghai Boshin Investment, with similar transfer restrictions as other new shares[26] Financial Audits - The company did not undergo an audit for the first quarter report[41]

Financial Performance - The company's operating revenue for 2021 was ¥539,773,421.30, representing a year-over-year increase of 1.60% compared to ¥531,269,507.27 in 2020[21]. - The net profit attributable to shareholders for 2021 was ¥70,124,270.08, a decrease of 15.24% from ¥82,732,790.35 in 2020[21]. - The net profit after deducting non-recurring gains and losses was ¥26,224,621.18, down 58.52% from ¥63,217,051.08 in 2020[21]. - The net cash flow from operating activities increased significantly by 275.50% to ¥26,452,979.25 from ¥7,044,644.73 in 2020[21]. - The total assets at the end of 2021 were ¥1,522,824,726.68, an increase of 8.22% from ¥1,407,181,784.90 at the end of 2020[21]. - The net assets attributable to shareholders increased by 31.60% to ¥1,079,897,413.46 from ¥820,617,690.61 at the end of 2020[21]. - The company reported a basic earnings per share of ¥0.6305, down 20.50% from ¥0.7931 in 2020[21]. - The overall gross margin declined due to rising raw material and labor costs, as well as increased market competition[48]. - The company achieved operating revenue of 540 million yuan in 2021, a year-on-year increase of 1.6%[48]. - Net profit attributable to the parent company was 70.12 million yuan, a decrease of 15.24% compared to the previous year[48]. Research and Development - The company has established a complete R&D system for membrane materials and separation technology, promoting continuous technological innovation[38]. - The company has invested CNY 42.9352 million in R&D, accounting for 7.95% of its revenue, ensuring continuous improvement in technology and product development capabilities[44]. - Research and development expenses increased year-on-year, contributing to the decline in net profit[49]. - The company has increased its R&D personnel by 17.74%, with a total of 73 R&D staff, which now constitutes 18.91% of the workforce[65]. - The company plans to develop and optimize organic membrane materials, enhancing its position in the separation membrane industry[65]. - The company's R&D investment in 2021 amounted to ¥42,935,151.10, representing 7.95% of total revenue, an increase from 5.44% in 2020[66]. Market Position and Strategy - The company is focused on the research and application of membrane materials and membrane separation technology, which are considered key strategic materials in the new materials industry[32]. - The company has established a strong position in the domestic ceramic membrane technology sector and has developed comprehensive membrane integration technology solutions[33]. - The total production value of China's separation membrane-related industry is expected to exceed ¥360 billion in 2022, indicating significant market growth potential[33]. - The company actively participates in the lithium battery supply chain, focusing on the core processes and materials for lithium extraction from salt lake brine[39]. - The company plans to strengthen strategic cooperation and market expansion, particularly in high-growth sectors such as lithium extraction from salt lakes and clean production of iron phosphate[92]. - The company aims to enhance project delivery efficiency and operational management capabilities while ensuring quality and cost reduction[93]. Corporate Governance - The company maintains a strong governance structure, adhering to relevant laws and regulations, and ensuring the protection of shareholder interests[101]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal and regulatory requirements[102]. - The company has established independent personnel management and compensation systems, ensuring that key management personnel are not involved with the controlling shareholder[106]. - The company has a dedicated audit risk control department that reports directly to the audit committee, enhancing internal audit effectiveness[107]. - The company has established a performance evaluation system linking the income of senior management to their work performance, ensuring accountability and motivation[103]. Environmental and Social Responsibility - The company has established an environmental management system in accordance with GB/T 24001-2016/ISO 14001:2015 standards to minimize negative environmental impacts[169]. - The company has not faced any administrative penalties due to environmental issues during the reporting period[170]. - The company actively engages in social welfare by providing scholarships to underprivileged university students, demonstrating its commitment to social responsibility[173]. - The company has implemented measures such as updating old equipment and promoting paperless operations to enhance environmental sustainability[173]. Shareholder Relations and Dividends - The company plans to distribute a cash dividend of 1.50 CNY per 10 shares, totaling 18,396,303.60 CNY for the year 2021[146]. - The cash dividend distribution represents 100% of the total profit distribution amount[146]. - The company has a clear profit distribution and cash dividend policy that complies with regulatory requirements[170]. - The company has implemented an employee stock incentive plan, with the first grant of restricted stock occurring on November 6, 2018, totaling 293,000 shares[153]. Risks and Challenges - The ongoing COVID-19 pandemic poses uncertainties that could adversely affect the company's overall performance, prompting the company to closely monitor developments and implement preventive measures[95]. - The company faces competition risks in the membrane separation industry, necessitating continuous R&D investment and market expansion efforts[93]. - The company anticipates an increase in accounts receivable due to business growth, with a focus on improving collection management and enhancing the proportion of quality customers to mitigate risks[94].

江苏久吾高科技股份有限公司 2021 年第三季度报告 证券代码：300631 证券简称：久吾高科 公告编号：2021-086 债券代码：123047 债券简称：久吾转债 江苏久吾高科技股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示: 1、董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法 律责任。 3、第三季度报告是否经过审计 （二）非经常性损益项目和金额 □ 是 √ 否 一、主要财务数据 （一）主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末比 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 上年同期增减 | | 营业收入（元） | 140,489,567.63 | 17.04% | 325,912,502.22 | 11.43% | | 归属于上市公司股东 | 11 ...

Financial Performance - The company's operating revenue for the reporting period was ¥185,422,934.59, representing a 7.53% increase compared to ¥172,436,700.87 in the same period last year[22]. - The net profit attributable to shareholders decreased by 57.59% to ¥8,906,046.49 from ¥21,000,729.44 year-on-year[22]. - The net profit after deducting non-recurring gains and losses was ¥3,966,971.27, down 48.89% from ¥7,761,989.66 in the previous year[22]. - The net cash flow from operating activities improved significantly to ¥5,012,085.69, a 218.97% increase from a negative cash flow of -¥4,213,060.84 in the same period last year[22]. - The total assets at the end of the reporting period were ¥1,325,705,759.37, a decrease of 5.79% from ¥1,407,181,784.90 at the end of the previous year[22]. - The company's basic earnings per share decreased by 59.36% to ¥0.0812 from ¥0.1998 year-on-year[22]. - The company's financial expenses increased by 348.20% to ¥4,322,790.76, primarily due to increased interest expenses from convertible bonds[46]. - The company's total liabilities decreased to approximately 484.20 million, down from 557.44 million at the end of the previous year[163]. Research and Development - The company focuses on the research and application of ceramic membranes and membrane separation technology, providing integrated solutions for industrial separation and environmental water treatment[29]. - R&D expenses accounted for 8.22% of the company's revenue during the reporting period, focusing on the optimization of aluminum and titanium adsorbent preparation processes[39]. - The company has established a complete R&D system for membrane materials and separation technology, promoting continuous technological advancement[32]. - The company has developed multiple core technologies in membrane separation, with most being at a leading domestic or advanced international level, which are crucial for maintaining its competitive edge[78]. - The company has taken steps to protect its core technologies through patent applications and confidentiality agreements with employees, although risks of technology leakage remain[78]. Market Position and Strategy - The company operates in various industrial sectors, including chemical, petrochemical, metallurgy, pharmaceuticals, food, and paper industries[13]. - The company has maintained a leading position in the membrane separation industry, facing competition that affects profit margins[76]. - The company is focused on expanding its market presence and enhancing R&D to maintain its competitive edge[77]. - The company aims to optimize management and reduce costs to sustain its industry leadership and performance[77]. - The company is addressing risks from downstream industry fluctuations by diversifying application fields and nurturing quality clients[77]. Corporate Governance - All directors attended the board meeting to review the report, ensuring comprehensive oversight[5]. - The financial report has been confirmed to be true, accurate, and complete by the company's management[4]. - The company emphasizes the importance of risk awareness regarding forward-looking statements made in the report[5]. - The company has not reported any changes in its registered address, office address, or contact information during the reporting period[18]. - The company has not made any changes to its information disclosure practices during the reporting period[19]. Shareholder Information - The company plans not to distribute cash dividends, issue bonus shares, or increase capital from reserves[6]. - The company has a stock incentive plan in place, with a total of 293,000 restricted shares granted to key personnel, representing 84.93% of the total incentive plan[88]. - The largest shareholder, Shanghai Dehui Group Co., Ltd., holds 29.46% of the shares, totaling 32,000,000 shares[135]. - The total number of shareholders at the end of the reporting period was 16,168[134]. - The company has maintained stable shareholder relationships, with no new strategic investors or mergers reported[136]. Fundraising and Financial Management - Total raised funds amounted to ¥24,558.17 million, with ¥98.44 million invested during the reporting period[62]. - The company has not made any changes to the use of raised funds during the reporting period[62]. - The company reported a net fundraising amount of RMB 245.58 million for the high-performance filtration membrane component and device industrialization project, with an investment completion deadline set for December 2022[65]. - The company has committed RMB 170 million in entrusted financial management, with RMB 130 million remaining outstanding[69]. - The company has not encountered any issues or other situations in the use and disclosure of fundraising[66]. Legal and Compliance - The company is involved in ongoing litigation regarding patent infringement, with claims amounting to CNY 1,331.3 million and CNY 2,019 million against various defendants[106]. - The company has initiated legal proceedings to recover overdue payments totaling CNY 75.9 million from a defendant, with the court supporting the company's claims[106]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[95]. - There were no significant asset or equity sales during the reporting period[73][74]. Risk Management - The company has detailed its risk management strategies in the report, highlighting potential operational risks[5]. - The ongoing uncertainty of the COVID-19 pandemic may adversely affect the company's overall business performance, prompting the company to closely monitor developments and implement preventive measures[79]. - The company has implemented measures to strengthen accounts receivable management, including establishing a dedicated team for collection efforts and enhancing customer credit assessments[78].

2021年04月 江苏久吾高科技股份有限公司 2021 年第一季度报告全文 证券代码：300631 江苏久吾高科技股份有限公司 2021年第一季度报告 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 第 1 页 江苏久吾高科技股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减 | | 营业收入（元） | 75,546,621.76 | 68,309,501.83 | 10.59% | | 归属于上市公司股东的净利润（元） | 6,638,128.99 | 7,667,214.06 | ...

Financial Performance - The company's operating revenue for 2020 was ¥531,269,507.27, representing a 7.56% increase compared to ¥493,948,395.76 in 2019[17]. - The net profit attributable to shareholders for 2020 was ¥82,732,790.35, a significant increase of 48.23% from ¥55,814,395.22 in 2019[17]. - The net profit after deducting non-recurring gains and losses was ¥63,217,051.08, up 31.94% from ¥47,913,876.35 in 2019[17]. - The company's total assets increased by 9.05% to ¥1,407,181,784.90 at the end of 2020, compared to ¥1,290,421,022.87 at the end of 2019[17]. - The basic earnings per share for 2020 was ¥0.7931, reflecting a 46.65% increase from ¥0.5408 in 2019[17]. - The company reported a net cash flow from operating activities of ¥7,044,644.73, a decrease of 88.20% from ¥59,707,863.02 in 2019[17]. - The company achieved a revenue of CNY 531.27 million in 2020, representing a year-on-year growth of 7.56%[42]. - The net profit attributable to the parent company was CNY 82.73 million, marking a significant increase of 48.23% compared to the previous year[42]. - Research and development expenses amounted to CNY 28.93 million, accounting for 5.44% of total revenue[43]. - The gross profit margin for the specialized equipment manufacturing industry was 42.54%, an increase of 1.78% compared to the previous year[49]. Dividend Policy - The company plans to distribute a cash dividend of 1.8 RMB per 10 shares to all shareholders based on a total share capital of 108,625,070 shares as of March 31, 2021[5]. - The proposed cash dividend for 2020 is 1.8 CNY per 10 shares, amounting to a total cash dividend of 19,552,512.60 CNY (including tax)[99][100]. - The cash dividend represents 23.63% of the net profit attributable to shareholders for the year 2020[101]. - The company has maintained a consistent cash dividend policy, with previous years' dividends being 1.5 CNY per 10 shares for 2018 and 2019[100][101]. - The cash dividend payout ratio for 2019 was 28.37%, and for 2018 it was 28.78%, indicating a stable dividend policy[101]. Research and Development - The company focuses on the research and application of ceramic membranes and membrane separation technology, providing integrated solutions for industrial separation and environmental water treatment[26]. - The company has established a complete R&D system for ceramic membranes and membrane separation technology, promoting continuous technological innovation[30]. - The company holds a total of 69 invention patents, 127 utility model patents, and 5 design patents, with 109 patent applications accepted[38]. - The company plans to invest 50 million in research and development to innovate new technologies over the next two years[200]. Market Position and Strategy - The company aims to become a leader in the membrane separation industry, focusing on innovation in membrane materials and technologies to support traditional industries' upgrades and contribute to energy conservation and circular economy efforts[89]. - The company will actively explore new application areas for ceramic membranes, including special water treatment and food and beverage sectors, to create new growth points[110]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[112]. - A strategic acquisition of a smaller tech firm was completed, which is anticipated to enhance the company's technological capabilities and increase market competitiveness[112]. Financial Management - The company received government subsidies amounting to ¥25,665,545.89 in 2020, compared to ¥8,613,939.80 in 2019[23]. - The company's fixed assets increased by 100.8% compared to the beginning of the period, primarily due to the completion and acceptance of IPO fundraising projects[35]. - Cash and cash equivalents decreased by 59.66% compared to the beginning of the period, mainly due to the purchase of trading financial assets and repayment of bank loans[35]. - The total cash inflow from financing activities decreased by 33.58% to 275,510,000.00 CNY, while cash outflow increased by 60.94% to 306,486,885.99 CNY, leading to a net cash flow from financing activities of -30,976,885.99 CNY[63]. Corporate Governance - The company has committed to ensuring the accuracy and completeness of its financial reports, with key personnel affirming the integrity of the annual report[4]. - The company has ensured that minority shareholders have had the opportunity to express their opinions and that their rights are adequately protected[97]. - The company has fulfilled all commitments made by its actual controllers and shareholders as of the report date[103]. - The company has a long-term commitment to comply with relevant laws and regulations regarding share transfers and repurchases[104]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements and potential operational risks in its future development outlook[5]. - The ongoing uncertainty of the COVID-19 pandemic may adversely affect the company's operations and performance, with a focus on monitoring developments and ensuring stable product and service delivery[93]. - The company is facing competition risks from both domestic and international players, which may impact profit margins; ongoing R&D investment and market expansion are essential to maintain its leading position[91]. Social Responsibility - The company actively participated in social responsibility initiatives, including donations during the COVID-19 pandemic[150]. - The company has established a scholarship fund to support outstanding students in need[150]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,078, down from 11,136 at the end of the previous month[171]. - The largest shareholder, Shanghai Dehui Group, holds 29.46% of the shares, totaling 32 million shares[171].

江苏久吾高科技股份有限公司 2020 年第三季度报告 2020 年 10 月 1 江苏久吾高科技股份有限公司 2020 年第三季度报告全文 江苏久吾高科技股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人党建兵、主管会计工作负责人范克银及会计机构负责人(会计主 管人员)晋欣蕾声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏久吾高科技股份有限公司 2020 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增 | | --- | --- | --- | --- | --- | | | | | | 减 | | 总资产（元） | 1,303,971,816.41 | | 1,290,421,022.87 | 1.05% | | 归属于上市公司股东的净 ...

Financial Performance - The company reported a revenue of RMB 300 million for the first half of 2020, representing a year-on-year increase of 15%[14]. - The net profit attributable to shareholders was RMB 50 million, up 20% compared to the same period last year[14]. - The company has set a revenue target of RMB 600 million for the full year 2020, reflecting a growth rate of 10%[14]. - The company's operating revenue for the reporting period was ¥172,436,700.87, representing a 7.94% increase compared to ¥159,749,229.86 in the same period last year[20]. - The net profit attributable to shareholders was ¥21,000,729.44, a significant increase of 67.03% from ¥12,573,241.39 year-on-year[20]. - Operating profit reached CNY 31.46 million, up 54.51% compared to the same period last year[55]. - The gross margin for membrane integration technology solutions was 40.03%, a slight decrease of 0.23% year-on-year[66]. - The company achieved a gross profit of CNY 69,364,285.73, resulting in a gross margin of approximately 40.2%[195]. - Total comprehensive income for the period reached ¥26,656,093.44, an increase from ¥16,913,632.72 in the previous period, representing a growth of approximately 57.5%[199]. Research and Development - The company plans to invest RMB 100 million in R&D for new membrane technologies in the upcoming year[14]. - Research and development expenses amounted to 14.35 million, accounting for 8.32% of operating income, indicating a strong commitment to innovation[47]. - Research and development expenses increased significantly to CNY 14,353,241.94, up from CNY 8,256,321.60, marking a rise of 73.0%[195]. - The company has established a complete R&D system for membrane materials and separation technology, driving continuous technological innovation[35]. - The company has accumulated 66 invention patents, 97 utility model patents, and 5 design patents, with 114 patent applications accepted[47]. - The company has developed multiple core technologies in membrane separation, with most being at a leading domestic or advanced international level[100]. Market Expansion and Strategy - User data indicates a 25% increase in the number of clients utilizing the company's membrane separation technology[14]. - The company is expanding its market presence in Southeast Asia, aiming for a 30% market share by the end of 2021[14]. - The company is exploring potential acquisitions to enhance its product offerings and market reach[14]. - The company is actively expanding into new application areas, including lithium extraction from salt lake brine and industrial wastewater treatment[55]. - The company aims to enhance its overall product value through comprehensive solutions and services tailored to customer needs[30]. Financial Management - No cash dividends will be distributed to shareholders for this fiscal year[6]. - The company's cash and cash equivalents decreased by 70.48% compared to the beginning of the period, primarily due to the repayment of bank loans[43]. - The company has reduced short-term borrowings by 92.77% compared to the beginning of the period, reflecting improved financial management[43]. - The company’s debt-to-asset ratio improved to 44.48% from 45.90%, a decrease of 1.42% year-over-year[175]. - The company maintained a loan repayment rate and interest payment rate of 100%[175]. - The company reported cash and cash equivalents of approximately ¥115.33 million, down from ¥390.65 million at the end of 2019[186]. Risks and Challenges - The company has identified risks related to supply chain disruptions and is implementing strategies to mitigate these risks[5]. - The company anticipates a gradual increase in accounts receivable due to economic slowdown and increased financing costs, impacting cash flow[99]. - The company is actively monitoring the impact of the COVID-19 pandemic on its operations and is taking measures to ensure stability while exploring market opportunities[101]. Corporate Governance and Compliance - The company has fulfilled commitments related to shareholding and asset restructuring as per regulations[107]. - The company has implemented a stock repurchase plan to stabilize its stock price, which will be activated if the stock price falls below the audited net asset value for 10 consecutive trading days[108]. - The company has not faced any penalties or corrective actions during the reporting period[117]. - There are no major litigation or arbitration matters during the reporting period[113]. - The company is involved in a lawsuit regarding patent infringement with a claim amount of 998.4 million yuan[114]. Subsidiaries and Investments - The subsidiary Anhui Jiuwu Tianhong Environmental Protection Technology Co., Ltd. has a registered capital of 6,000,000 RMB and generated a net profit of 11,541,559 RMB during the reporting period[93]. - Nanjing Jiuwu Petrochemical Engineering Co., Ltd., a subsidiary, has a registered capital of 1,000,000 RMB and reported a net profit of 96,717.27 RMB[93]. - The company has a total asset value of 55,857,940 RMB for its subsidiary Anhui Jiuwu Tianhong Environmental Protection Technology Co., Ltd.[93]. - The company has a total asset value of 3,358,033.00 RMB for its subsidiary Nanjing Jiuwu Petrochemical Engineering Co., Ltd.[93]. Shareholder Information - The total number of shares increased from 105,554,000 to 105,554,000, with no new shares issued[147]. - The company distributed a cash dividend of RMB 1.5 per 10 shares to all shareholders, with no bonus shares issued[169]. - The largest shareholder, Shanghai Dehui Group Co., Ltd., holds 30.32% of the shares, totaling 32,000,000 shares[158]. - The company issued 2,540,000 convertible bonds, raising a total of 254 million yuan[153]. - The conversion price was adjusted to RMB 17.61 per share after the annual profit distribution, effective from July 10, 2020[169][170].